Drug profile · INN
decitabine + cedazuridine
INQOVI 35/100
decitabine + cedazuridine (INQOVI 35/100) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — decitabine + cedazuridine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
decitabine + cedazuridine (INQOVI 35/100) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is decitabine + cedazuridine?
decitabine + cedazuridine (INQOVI 35/100) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for decitabine + cedazuridine?
INQOVI 35/100 is a marketed brand name for decitabine + cedazuridine. Check FDA Drugs@FDA for the current US label holder and prescribing information.